论文部分内容阅读
目的：观察噻肟单酰胺菌素治疗尿路感染的临床疗效和安全性．方法：选择尿路感染病例114例，随机分成2组；治疗组60例（男11例，女49例，年龄（43±15岁），其中复杂性尿路感染病人24例．对照组54例（男12例、女42例，年龄（41±15岁），其中复杂性尿路感染13例．治疗组给予噻肟单酰胺菌素1．2-2.0g加入生理盐水中250ml中静滴，一日2次，疗程7-14d．对照组给予丁胺卡那霉素0．2g加入生理盐水250ml中静滴，一日1次，疗程7－14d．结果：治疗组总有效率63．3％，对照组总有效率64．8％，治疗组疗效明显优于对照组（P＜0.05）．结论：噻肟单酰胺菌素治疗尿路感染，特别是上尿路感染疗效好，安全性高．
Objective: To observe the clinical efficacy and safety of thiamectin in the treatment of urinary tract infection. Methods: A total of 114 cases of urinary tract infection were selected and randomly divided into two groups: 60 cases in the treatment group (11 males and 49 females, age 43 ± 15 years), including 24 patients with complicated urinary tract infection (12 males and 42 females, age (41 ± 15 years), including 13 cases of complicated urinary tract infection.The treatment group was given intravenous infusion of 1,2-2.0 g of dexamethasone in 250 ml normal saline, 2 times a day, the course of treatment 7-14d. The control group given amikacin 0.2g intravenous infusion of 250ml normal saline once a day for 7-14 days.Results: The total effective rate of the treatment group was 63.3 %, The control group, the total effective rate was 64.8%, the treatment group was significantly better than the control group (P <0.05) .Conclusion: The side effects of thiazolyl monofactin in the treatment of urinary tract infections, especially the upper urinary tract infection is good and safe high.